These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 37554106)
21. Identification of oxidative stress-related genes differentially expressed in Alzheimer's disease and construction of a hub gene-based diagnostic model. Zhang Y; Kiryu H Sci Rep; 2023 Apr; 13(1):6817. PubMed ID: 37100862 [TBL] [Abstract][Full Text] [Related]
22. Data-Driven Modeling of Knowledge Assemblies in Understanding Comorbidity Between Type 2 Diabetes Mellitus and Alzheimer's Disease. Karki R; Madan S; Gadiya Y; Domingo-Fernández D; Kodamullil AT; Hofmann-Apitius M J Alzheimers Dis; 2020; 78(1):87-95. PubMed ID: 32925069 [TBL] [Abstract][Full Text] [Related]
23. Shared Causal Paths underlying Alzheimer's dementia and Type 2 Diabetes. Hu Z; Jiao R; Wang P; Zhu Y; Zhao J; De Jager P; Bennett DA; Jin L; Xiong M Sci Rep; 2020 Mar; 10(1):4107. PubMed ID: 32139775 [TBL] [Abstract][Full Text] [Related]
24. Exploring the Potential Role of Oligodendrocyte-Associated PIP4K2A in Alzheimer's Disease Complicated with Type 2 Diabetes Mellitus via Multi-Omic Analysis. Nguyen DPQ; Jallow AW; Lin YF; Lin YF Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928345 [TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer's disease by regulating microbiome Zheng R; Shi S; Zhang Q; Yuan S; Guo T; Guo J; Jiang P Front Cell Infect Microbiol; 2023; 13():1140945. PubMed ID: 37009506 [TBL] [Abstract][Full Text] [Related]
26. Glucometabolic-Related Genes as Diagnostic Biomarkers and Therapeutic Targets for Alzheimer's Disease and Type 2 Diabetes Mellitus: A Bioinformatics Analysis. Liu S; Chen H; He XD; Yang XO Neurol Res Int; 2024; 2024():5200222. PubMed ID: 38595695 [TBL] [Abstract][Full Text] [Related]
27. Bioinformatics analysis of the potential mechanisms of Alzheimer's disease induced by exposure to combined triazine herbicides. Li J; Qi L; Chen Y; Lv H; Bi H Ann Hum Biol; 2023 Feb; 50(1):442-451. PubMed ID: 37819172 [TBL] [Abstract][Full Text] [Related]
28. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease. Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853 [TBL] [Abstract][Full Text] [Related]
29. Identification of therapeutic targets for Alzheimer's disease via differentially expressed gene and weighted gene co-expression network analyses. Jia Y; Nie K; Li J; Liang X; Zhang X Mol Med Rep; 2016 Nov; 14(5):4844-4848. PubMed ID: 27748870 [TBL] [Abstract][Full Text] [Related]
30. Mechanism of quercetin therapeutic targets for Alzheimer disease and type 2 diabetes mellitus. Zu G; Sun K; Li L; Zu X; Han T; Huang H Sci Rep; 2021 Nov; 11(1):22959. PubMed ID: 34824300 [TBL] [Abstract][Full Text] [Related]
31. Cross-disease analysis of Alzheimer's disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases. Caberlotto L; Nguyen TP; Lauria M; Priami C; Rimondini R; Maioli S; Cedazo-Minguez A; Sita G; Morroni F; Corsi M; Carboni L Sci Rep; 2019 Mar; 9(1):3965. PubMed ID: 30850634 [TBL] [Abstract][Full Text] [Related]
32. Detection of molecular signatures and pathways shared by Alzheimer's disease and type 2 diabetes. Shu J; Li N; Wei W; Zhang L Gene; 2022 Feb; 810():146070. PubMed ID: 34813915 [TBL] [Abstract][Full Text] [Related]
33. Network pharmacology and molecular docking approaches to elucidate the potential compounds and targets of Saeng-Ji-Hwang-Ko for treatment of type 2 diabetes mellitus. Ko M; Kim Y; Kim HH; Jeong S; Ahn D; Chung SJ; Kim H Comput Biol Med; 2022 Oct; 149():106041. PubMed ID: 36049411 [TBL] [Abstract][Full Text] [Related]
34. Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics. Wang F; Xu J; Xu SJ; Guo JJ; Wang F; Wang QW J Alzheimers Dis; 2022; 85(2):729-744. PubMed ID: 34776447 [TBL] [Abstract][Full Text] [Related]
35. Network pharmacology and bioinformatics approach reveals the therapeutic mechanism of action of curcumin in Alzheimer disease. Vijh D; Imam MA; Haque MMU; Das S; Islam A; Malik MZ Metab Brain Dis; 2023 Apr; 38(4):1205-1220. PubMed ID: 36652025 [TBL] [Abstract][Full Text] [Related]
36. A Comprehensive Investigation of Molecular Signatures and Pathways Linking Alzheimer's Disease and Epilepsy via Bioinformatic Approaches. Wu J; Zhu S; Zhao C; Xu X Curr Alzheimer Res; 2022; 19(2):146-160. PubMed ID: 35114922 [TBL] [Abstract][Full Text] [Related]
37. Analysis of Shared Genetic Regulatory Networks for Alzheimer's Disease and Epilepsy. Wang XD; Liu S; Lu H; Guan Y; Wu H; Ji Y Biomed Res Int; 2021; 2021():6692974. PubMed ID: 34697589 [TBL] [Abstract][Full Text] [Related]
38. ε3/4 genotype of the apolipoprotein E is associated with higher risk of Alzheimer's disease in patients with type 2 diabetes mellitus. Tang Y; Li YM; Zhang M; Chen YQ; Sun Q Gene; 2019 Jun; 703():65-70. PubMed ID: 30890475 [TBL] [Abstract][Full Text] [Related]
39. Articulating target-mining techniques to disinter Alzheimer's specific targets for drug repurposing. G N S HS; Marise VLP; Rajalekshmi SG; Burri RR; Krishna Murthy TP Comput Methods Programs Biomed; 2022 Jul; 222():106931. PubMed ID: 35724476 [TBL] [Abstract][Full Text] [Related]
40. Integrated Bioinformatics Analysis to Identify Alternative Therapeutic Targets for Alzheimer's Disease: Insights from a Synaptic Machinery Perspective. Ceylan H J Mol Neurosci; 2022 Feb; 72(2):273-286. PubMed ID: 34414562 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]